COVID-19 Panel Discussion: How to optimise clinical trial and regulatory outcomes after COVID-19 disruption
COVID-19 Panel Discussion: Successful Medical Affairs in the “New Normal” after COVID-19
COVID-19 Panel Discussion: Navigating translational/early clinical development during COVID-19